Pfizer CEO Bourla granted 22 phantom stock units

Pfizer’s CEO received a small grant of cash-settled phantom stock units under a deferred compensation plan, raising his total phantom units to 783,985.

Rhea-AI Filing Summary

PFIZER INC (symbol: PFE) is the issuer of record for a Form 4 filing submitted to the SEC. BOURLA ALBERT reported acquisition or exercise transactions in this Form 4 filing.

PFIZER INC (PFE) reported that Chairman & CEO Albert Bourla received an award of 22 Phantom Stock Units SSP on September 15, 2026. Each unit represents one phantom share of common stock and was valued at $27.55 per unit, increasing his directly held phantom stock units to 783,985. The units were granted under Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan and will be settled in cash following his separation from service, with flexibility to transfer them into an alternative investment account at any time.

Insider Trade Summary

Grant/Award: 22 shares

Grant/Award 1 txn

Insider BOURLA ALBERT

Role Chairman & CEO

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units SSP F1, F2	22	$27.55	$606.10

Holdings After Transaction: Phantom Stock Units SSP — 783,985 contracts (Direct)

Footnotes (2)

1. F1. Each unit represents one phantom share of common stock.
2. F2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Key Figures

Phantom Stock Units granted: 22 units Grant value per Phantom Stock Unit: $27.55 per unit Total Phantom Stock Units after transaction: 783,985 units +1 more

4 metrics

Phantom Stock Units granted 22 units Grant to Albert Bourla on September 15, 2026

Grant value per Phantom Stock Unit $27.55 per unit Value assigned to the September 15, 2026 award

Total Phantom Stock Units after transaction 783,985 units Directly held by Albert Bourla following the award

Underlying common stock equivalence 1 share per unit Each Phantom Stock Unit represents one phantom share of common stock

Key Terms

Phantom Stock Units, Nonfunded Deferred Compensation and Supplemental Savings Plan, separation from service, alternative investment account

4 terms

Phantom Stock Units financial

"Each unit represents one phantom share of common stock"

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Nonfunded Deferred Compensation and Supplemental Savings Plan financial

"acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan"

separation from service financial

"are settled in cash following the reporting person's separation from service"

alternative investment account financial

"may be transferred by the reporting person into an alternative investment account"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pfizer (PFE) report for Albert Bourla on September 15, 2026?

Pfizer reported that Albert Bourla received a grant of 22 Phantom Stock Units SSP on September 15, 2026, as a compensation-related award, increasing his directly held phantom stock units to 783,985 under a company deferred compensation plan.

What are the Phantom Stock Units reported for Pfizer (PFE) CEO Albert Bourla?

Each Phantom Stock Unit represents one phantom share of Pfizer common stock. These units are part of Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan and are settled in cash after Albert Bourla’s separation from service, rather than in actual shares.

How many Pfizer (PFE) phantom stock units does Albert Bourla hold after this Form 4 transaction?

After the September 15, 2026 award, Albert Bourla holds 783,985 Phantom Stock Units SSP directly. This total includes the newly granted 22 units reported in the Form 4 filing for that date.

At what value were the new Pfizer (PFE) Phantom Stock Units for Albert Bourla recorded?

The 22 newly awarded Phantom Stock Units SSP for Albert Bourla were recorded at $27.55 per unit. Each unit corresponds to one phantom share of Pfizer common stock and is part of a cash-settled deferred compensation arrangement.

Will Pfizer (PFE) issue shares for Albert Bourla’s Phantom Stock Units?

No. The filing states these Phantom Stock Units are settled in cash following Albert Bourla’s separation from service. They are granted under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan and do not involve issuance of actual shares.

Was Albert Bourla’s Pfizer (PFE) phantom stock transaction under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, and the footnotes do not reference any Rule 10b5-1 or pre-arranged trading plan for this compensation-related award of Phantom Stock Units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 03:18 PM Accepted by SEC EDGAR 09/16/2026 - 03:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOURLA ALBERT

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units SSP	(1)	09/15/2026		A		22		(2)	(2)	Common Stock	22	$27.55	783,985	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

	/s/ Shanice A. Reid, by power of atty., for Albert Bourla	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)